Page 139 - Malaysian Journal of Health Promotion, Vol 4 (Supplementary 1) 2022
P. 139

Malaysian Journal of Health Promotion, Vol 4 (Supplementary 1) 2022
                      14  MOH-AMM Scientific Meeting 2022 in conjunction with 23  NIH Scientific Conference Abstract Book
                                                                    rd
                        th
               severe  normocytic  normochromic  anaemia,  leucocytosis  with  neutrophilia  and  marked
               rouleaux formation. The patient was treated as septic shock secondary community-acquired
               pneumonia and severe anemia in ward. In view of severe anaemia, both protein quantitation
               and profiling of Transferrin were requested. Profiling of Transferrin isoform was determined
               using Carbohydrate-Deficient Transferrin (CDT) analysis. Transferrin quantitation showed low
               value of 1.17 g/L and Transferrin isoform  showed presence of additional peak appearing
               anodic to Sialo 0-tf, which represent immunoglobulin (Ig) or monoclonal interferences. This
               monoclonal  peak  was  further  identified  using  serum  protein  electrophoresis  and
               immunofixation  analysis.  Presence  of  IgG  Lambda  paraproteinaemia  was  discovered  with
               concentration of 60.38 g/L. An additional Serum free light chain test was carried out and the
               result showed low ratio level of Kappa to Lambda of 0.02.
               CONCLUSION: Monoclonal proteins may be incidental findings at CDT CZE and may indicate
               malignant  or  premalignant  conditions.  Therefore,  it  should  be  reported  regardless  of  its
               concentration to the ordering physician.

               ID 182 DISTRIBUTION OF ARYLSULPHATASE A LEVELS IN PLASMA OF PATIENTS WITH LACTIC
               ACIDOSIS

                                             1
                                                                     1
                                                                                    1
                          1
                                                                                                        1
               Affandi Omar , Salina Abdul Rahman , Fatimah Diana Amin Nordin , Balqis Kamarudin , Nur Jannaim Muhamad ,
                                  2
               Fatin Nurin Najma Latif , Julaina Abdul Jalil 1
               1 Inborn Errors of Metabolism & Genetic Unit, Nutrition, Metabolism & Cardiovascular Research Centre (NMCRC),
               Institute for Medical Research, National Institutes of Health
               2 Faculty of Science and Marine Environment, Universiti Malaysia Terengganu, Malaysia

               INTRODUCTION: Lactic acidosis is one of many clinical presentations related to mitochondrial
               disorders (MD). Current laboratory diagnosis is based on skin biopsy which is invasive to the
               patients. Arylsulphatase A (ARSA) functions as a lysosomal enzyme also known to be related
               with metachromatic leukodystrophy (MLD) and Parkinson’s Disease (PD). However, there is
               little information about the relationship of ARSA level in patients with lactic acidosis. Here,
               we investigated the ARSA level potentiality to be used as an MD fluid biomarker.
               METHODS: Plasma ARSA level was measured in 31 high-risk patients with high lactate and 40
               healthy  controls.  We  compared  the  plasma  ARSA  level  among  the  groups  using  Mann-
               Whitney U test and assessed its correlation using Spearman’s rho correlation coefficient.
               RESULTS: Plasma ARSA level was not correlated with gender, organomegaly presentation and
               seizures  (p>0.05).  Patients  with high  lactate  had  lower plasma  ARSA  level  (median  =  110
               nmol/ml/hour;  min,  max  value  =  35.93,  347.33)  than  the  control  group  (median  =  177
               nmol/ml/hour; min, max value = 107.58; 326.76) (p<0.05). In the high-risk patients with lactic
               acidosis,  plasma  ARSA  was  negatively  correlated  to  lactate  level  (r=-0.486)  and  alkaline
               phosphatase  (r=-0.463)  while  positively  correlated  to  age  group  (r=0.465).  High  level  of
               lactate anion might act as inhibitor to ARSA and reduce the capabilities of ARSA.
               DISCUSSION/CONCLUSION: In summary, reduction in plasma ARSA in patients with lactic
               acidosis,  were  associated  with  MD.  Therefore,  these  results  suggest  that  ARSA  level  is  a
               potential biomarker for patients suspected with MD.

               ID 183 IMPACT OF GLUCOSE TOWARDS ARYLSULPHATASE A ACTIVITY IN PLASMA

                                                                     1
                                                  1
                                                                                                        1
                                                                                    1
                                      1
               Fatimah Diana Amin Nordin , Affandi Omar , Salina Abdul Rahman , Balqis Kamarudin , Nur Jannaim Muhamad ,
                                  2
               Fatin Nurin Najma Latif , Julaina Abdul Jalil 1
                                                                                                      113
   134   135   136   137   138   139   140   141   142   143   144